Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ROBERT LOUIS COLEMAN

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology

NPI
1669570685
CMS profile
256843
Location
HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$104,853.83

42 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $32,254.62 8
AstraZeneca Pharmaceuticals LP $23,246.71 11
AstraZeneca UK Limited $17,125.00 4
Merck Sharp & Dohme Corporation $10,750.00 4
Clovis Oncology, Inc. $4,500.00 2
PFIZER INC. $3,700.00 1
Myriad Genetic Laboratories, Inc. $3,000.00 2
Taiho Oncology, Inc. $2,952.50 5
Genentech, Inc. $2,640.00 1
Seagen Inc. $2,300.00 1
Deciphera Pharmaceuticals Inc. $1,200.00 1
F. Hoffmann-La Roche AG $660.00 1
AbbVie Inc. $525.00 1

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

42 matching records · $104,853.83 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 42 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–42 of 42.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $3,700.0012/28/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743809567 CMS
Deciphera Pharmaceuticals Inc. $1,200.0012/23/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736768839 CMS
AstraZeneca Pharmaceuticals LP $7,535.0012/21/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736445031 CMS
AstraZeneca UK Limited $5,822.5012/10/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026735762827 CMS
Merck Sharp & Dohme Corporation $5,500.0011/20/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747831683 CMS
Merck Sharp & Dohme Corporation $500.0011/02/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747834861 CMS
Merck Sharp & Dohme Corporation $750.0010/28/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747830083 CMS
GlaxoSmithKline, LLC. $1,300.0010/27/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026753905885 CMS
AstraZeneca UK Limited $7,192.5010/21/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026735937793 CMS
AstraZeneca UK Limited $3,425.0010/21/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736429023 CMS
Clovis Oncology, Inc. $1,500.0010/14/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026722235715 CMS
GlaxoSmithKline, LLC. $3,900.0010/13/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026753907573 CMS
Seagen Inc. $2,300.0009/23/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026732453145 CMS
Genentech, Inc. $2,640.0008/21/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743093679 CMS
Myriad Genetic Laboratories, Inc. $1,500.0007/15/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727387183 CMS
GlaxoSmithKline, LLC. $975.0007/06/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738721833 CMS
AstraZeneca Pharmaceuticals LP $4,110.0007/02/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026735817995 CMS
Clovis Oncology, Inc. $3,000.0007/02/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026722235477 CMS
GlaxoSmithKline, LLC. $5,850.0007/02/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738496479 CMS
GlaxoSmithKline, LLC. $6,748.5406/23/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738865771 CMS
AbbVie Inc. $525.0006/12/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026721735353 CMS
AstraZeneca Pharmaceuticals LP $342.5005/24/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736177147 CMS
Merck Sharp & Dohme Corporation $4,000.0005/20/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747617865 CMS
AstraZeneca Pharmaceuticals LP $2,055.0004/29/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736323877 CMS
AstraZeneca Pharmaceuticals LP $1,027.5004/21/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736192695 CMS
Myriad Genetic Laboratories, Inc. $1,500.0004/17/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727387177 CMS
F. Hoffmann-La Roche AG $660.0003/28/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743093687 CMS
AstraZeneca UK Limited $685.0003/27/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736389453 CMS
Taiho Oncology, Inc. $115.7302/20/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026724400623 CMS
AstraZeneca Pharmaceuticals LP $4,110.0002/16/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736183705 CMS
AstraZeneca Pharmaceuticals LP $3,950.0002/16/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736253769 CMS
AstraZeneca Pharmaceuticals LP $15.4002/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736266447 CMS
AstraZeneca Pharmaceuticals LP $22.7102/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026735936471 CMS
AstraZeneca Pharmaceuticals LP $63.0002/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736262323 CMS
Taiho Oncology, Inc. $2,000.0001/30/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026724400621 CMS
GlaxoSmithKline, LLC. $13,170.5401/16/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738582235 CMS
GlaxoSmithKline, LLC. $193.0901/16/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738605765 CMS
GlaxoSmithKline, LLC. $117.4501/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738617949 CMS
Taiho Oncology, Inc. $141.4501/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026724400617 CMS
Taiho Oncology, Inc. $223.4201/15/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026724400619 CMS
Taiho Oncology, Inc. $471.9001/13/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026724400615 CMS
AstraZeneca Pharmaceuticals LP $15.6001/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026735995101 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $103,657.92 126
PY2020 $104,853.83 42
PY2021 $114,538.85 58
PY2022 $117,948.85 73
PY2023 $91,378.46 66
PY2024 $195,420.70 89
PY2025 $136,279.32 107

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
ROBERT LOUIS COLEMAN, NPI 1669570685. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1669570685.
APA 7
IndustryPayments. (2026). ROBERT LOUIS COLEMAN, NPI 1669570685 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1669570685
Bluebook
ROBERT LOUIS COLEMAN, NPI 1669570685, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1669570685.

Source: Centers for Medicare & Medicaid Services, Open Payments.